TCG GreenChem
TCG GreenChem is a US-based pharmaceutical CDMO and US subsidiary of India's TCG Lifesciences, providing process R&D, continuous flow chemistry, and USFDA-approved cGMP API manufacturing to global pharma, biotech, and generic-drug companies from facilities in New Jersey, Kolkata, and Hyderabad.
- Company typePrivate
- Founded2019
- HeadquartersTrenton, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What TCG GreenChem does
TCG GreenChem, Inc. is a US-headquartered pharmaceutical Contract Development and Manufacturing Organization (CDMO) and the US subsidiary of TCG Lifesciences Pvt. Ltd. (formerly Chembiotek Research International), a Contract Research and Manufacturing Services (CRAMS) platform founded in Kolkata, India in 2001. Founded in 2019 by Dr. Chris H. Senanayake (CEO & CSO) and Dr. Joseph D. Armstrong III (COO), the company is incorporated in New Jersey and operates a process R&D center in Ewing (Princeton South) with USFDA-approved cGMP manufacturing capacity at parent-owned facilities in Kolkata and Hyderabad, India. Its product surface centers on two proprietary technology platforms — ARDEL (Automated Reaction Design and Engineering Lab), a high-throughput experimentation engine for catalyst and reaction screening, and CFL (Continuous Flow Technology Lab), which converts batch chemistry into continuous processes for hazardous or extreme-condition reactions — integrated with a broad catalysis toolkit spanning asymmetric catalysis, biocatalysis, C-H activation, hydrocyanation, and more.
The company monetizes through fee-for-service CDMO contracts, providing end-to-end CMC services from process research and development (mg to cGMP scale) through analytical method validation, solid-state characterization, and cGMP API manufacturing for clinical and commercial supply. Customers are global pharmaceutical, biotechnology, and generic-drug companies, with one disclosed customer (Krouzon Pharmaceuticals) and a recent strategic alliance with Indena (2025). Pricing is quote-based and not publicly disclosed, consistent with custom contract-manufacturing engagements.
Go-to-market is enterprise field sales led by a direct business development team, supplemented by industry-conference presence (CPhI North America, ISCCET, ETH Zurich Behringer Simon Lecture) and scientific publication credibility. The 1,300+ scientist talent pool across TCGLS, including 300+ PhDs and leadership with prior tenures at Boehringer Ingelheim, Merck, Sepracor, Syngene, and AstraZeneca, functions as a primary sales asset in a relationship-driven CDMO market.
TCG GreenChem firmographics
Firmographics- Name
- TCG GreenChem
- Legal name
- TCG GreenChem, Inc.
- Website
- https://tcggreenchem.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- TCG GreenChem is a US-based pharmaceutical CDMO and US subsidiary of India's TCG Lifesciences, providing process R&D, continuous flow chemistry, and USFDA-approved cGMP API manufacturing to global pharma, biotech, and generic-drug companies from facilities in New Jersey, Kolkata, and Hyderabad.
- Ownership category
- akta.pro rank
TCG GreenChem industry classification
Industry- Product category
- Pharmaceutical CDMO Services
- NAICS
- Pharmaceutical and Medicine Manufacturing (3254), Scientific Research and Development Services (5417), Pharmaceutical and Medicine Manufacturing (32541)
- SIC
- Services-Commercial Physical & Biological Research (8731), Pharmaceutical Preparations (2834), Services-Testing Laboratories (8734)
- akta.pro primary industry
- Small-Molecule API & Intermediates CDMO (HLAGABAA)
- akta.pro secondary industries
- Drug Substance–Drug Product Integrated CDMO (HLAGABAG), Small-Molecule API Commercial Manufacturing (HLAGAHAB), GMP Scale-Up, Tech Transfer & Process Validation (PPQ) (HLAGAHAL), CMC & Pharmaceutical Development (Formulation/Process/Analytical Development) (HLAIALAD), Clinical Trial Material (CTM) Manufacturing & Supply CDMO (HLAGABAK)
Keywords
Where TCG GreenChem is headquartered
LocationHeadquarters
- HQ city
- Trenton
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
TCG GreenChem business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- CDMO Contract Research and Manufacturing Services: TCG GreenChem provides end-to-end CMC development services from process research and development through cGMP API manufacturing. Revenue is generated through fee-for-service contracts for pharmaceutical R&D, process development, analytical services, and cGMP manufacturing of intermediates and APIs for clinical and commercial supply.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
TCG GreenChem product offering
Product offeringCore offering
TCG GreenChem is a pharmaceutical CDMO that provides end-to-end CMC development services from process research and development through cGMP API manufacturing. The company's offerings span process R&D, analytical R&D and quality control, pharmaceutical solid state characterization and crystallization development, analytical method validation, and USFDA-approved cGMP API manufacturing for clinical and commercial supply. It is differentiated by its proprietary ARDEL high throughput experimentation platform and CFL continuous flow chemistry lab, integrated within a US-India manufacturing model serving global pharmaceutical, biotech, and generic industry clients.
Product overview
TCG GreenChem offers an integrated CDMO (Contract Development and Manufacturing Organization) platform combining two core technology labs—ARDEL (Automated Reaction Design and Engineering Lab) and CFL (Continuous Flow Technology Lab)—with comprehensive service offerings spanning the drug development pipeline from process research through cGMP API manufacturing. The company provides process R&D, analytical services, solid state characterization, crystallization development, and US FDA-approved manufacturing capabilities across facilities in New Jersey, USA and India.
Differentiator
Problem solved
Functional benefit
Products and services
- Process Research & Development Scalable synthesis development services for pharmaceutical intermediates and APIs with emphasis on green and sustainable manufacturing processes, supporting clients from process research through scale-up.
- Analytical R&D and Quality Control
- Pharmaceutical Solid State Physicochemical Characterization and Crystallization Development
- Analytical Method Validation (US FDA Certified)
- cGMP API Manufacturing
- ARDEL (Automated Reaction Design and Engineering Lab) and Services
- CFL (Continuous Flow Technology Lab)
- US FDA Approved API Manufacturing Facility
- Flow Chemistry Technology Services
- Drug Product Development
Quantifiable outcome
- Accelerated IND enabling toxicity studies and CMC requirements for Phase I clinical studies, shortening overall drug development timeline
- +1 more outcomes
Companies that use TCG GreenChem
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles2 records
TCG GreenChem technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
TCG GreenChem partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and flagship.
- IndenacoreTCG GreenChem and Indena entered into a strategic alliance to solve global CDMO challenges. The partnership combines TCG GreenChem's process chemistry, catalysis, and flow chemistry capabilities with Indena's expertise to offer comprehensive solutions to pharmaceutical clients worldwide. The alliance addresses supply chain resilience and regulatory compliance challenges in the CDMO industry.
- Krouzon PharmaceuticalscoreKrouzon Pharmaceuticals entered into an R&D and Commercial Manufacturing Agreement with TCG GreenChem Inc. TCG GreenChem will provide research and development services as well as commercial manufacturing capabilities for active pharmaceutical intermediates and APIs on behalf of Krouzon Pharmaceuticals.
- TCG Lifesciences Pvt. Ltd.flagshipTCG GreenChem, Inc. is the US subsidiary of TCG Lifesciences Pvt. Ltd. (formerly Chembiotek Research International), a leading global CRAMS company in drug discovery, development and commercialization. TCG Lifesciences started operations in 2001 in Kolkata, India. The synergy between TCG Lifesciences in India and TCG GreenChem in the USA enables cost arbitrage without compromising quality or speed. TCG Lifesciences also has an FDA-approved facility in Hyderabad (Clininvent) with pilot plant and commercialization suites for APIs.
Scale indicators7 records
Recent moves6 records
Expansion highlights5 records
TCG GreenChem competitors and assessment
Company assessmentBroad incumbents
- Cambrex: Established US-headquartered small-molecule API CDMO with multiple manufacturing sites and broader service portfolio—comparable end market (small-molecule API manufacturing) but significantly larger scale and broader capabilities.
- Lonza Group: World's largest CDMO with broad small-molecule API capabilities, flow chemistry, and commercial manufacturing—represents the upper-bound competitor in scale and global reach.
- Curia (formerly AMRI): Global CDMO with API development and manufacturing, drug product services, and integrated CMC offerings—comparable services but broader portfolio including biologics and analytical services.
- WuXi STA (WuXi AppTec): Global CDMO with large-scale small-molecule API manufacturing and integrated CMC services—comparable in service scope but substantially larger capacity and global footprint.
Direct peers
- Syngene International: India-based integrated CRO-CDMO serving global pharma with discovery, development, and manufacturing services. Particularly relevant given TCG GreenChem's Managing Director (Goutam Das) was previously COO of Syngene for 17 years.
- Sai Advantium Pharma (formerly Advinus Therapeutics): India-based CDMO offering integrated drug discovery, process development, and API manufacturing for global innovators—comparable in India-origin, US-India bridge model, and small-molecule focus.
- Sai Life Sciences: India-based CDMO providing process R&D, API manufacturing, and integrated CMC services for global pharma, with strong flow chemistry capabilities—comparable scope, customer base, and India-cost-arbitrage business model.
- Piramal Pharma Solutions: Indian-headquartered CDMO with US-India integrated model and FDA-approved facilities offering small-molecule API development, process R&D, and commercial manufacturing—closely mirroring TCG GreenChem's positioning, scale, and US-India cost arbitrage model.
- Anthem Biosciences: India-based CDMO offering process R&D, custom synthesis, and cGMP API manufacturing with strong scientific leadership—comparable in size, scope, and customer overlap.
- Aragen Life Sciences (formerly GVK Bio): Indian CRDMO with large scientific workforce providing discovery, development, and manufacturing services including small-molecule API—comparable in talent scale, India footprint, and global pharma customer base.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
TCG GreenChem social profiles
Digital presenceTCG GreenChem financial estimates
Financial estimateRevenue estimate
Valuation estimate
TCG GreenChem leadership team
Management profileNumber of profiles
Profiles7 records
TCG GreenChem funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
TCG GreenChem M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about TCG GreenChem
What does TCG GreenChem do?
TCG GreenChem is a pharmaceutical CDMO that provides end-to-end CMC development services from process research and development through cGMP API manufacturing. The company's offerings span process R&D, analytical R&D and quality control, pharmaceutical solid state characterization and crystallization development, analytical method validation, and USFDA-approved cGMP API manufacturing for clinical and commercial supply. It is differentiated by its proprietary ARDEL high throughput experimentation platform and CFL continuous flow chemistry lab, integrated within a US-India manufacturing model serving global pharmaceutical, biotech, and generic industry clients.
Is TCG GreenChem a public or private company?
TCG GreenChem is a private company. It is classified as corporate owned and is currently operating.
When was TCG GreenChem founded?
TCG GreenChem was founded in 2019. It employs 11 to 50 people.
Where is TCG GreenChem based?
TCG GreenChem is headquartered in Trenton, United States, in the North America region.
How does TCG GreenChem make money?
One revenue line is on record: CDMO Contract Research and Manufacturing Services.
Who are TCG GreenChem's main competitors?
Broad incumbents on record are Cambrex, Lonza Group, Curia (formerly AMRI) and WuXi STA (WuXi AppTec). Direct peers are Syngene International, Sai Advantium Pharma (formerly Advinus Therapeutics), Sai Life Sciences, Piramal Pharma Solutions, Anthem Biosciences and Aragen Life Sciences (formerly GVK Bio).
Does TCG GreenChem have an API?
No public API is recorded for TCG GreenChem.
What industry is TCG GreenChem in?
TCG GreenChem's product category is Pharmaceutical CDMO Services. Its primary akta.pro industry code is HLAGABAA, Small-Molecule API & Intermediates CDMO, with a secondary code of HLAGABAG, Drug Substance–Drug Product Integrated CDMO. Its NAICS code is 3254 and its SIC code is 8731.